| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |